Cell Culture Market

Cell Culture Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Cell Culture Market Outlook 2031

  • The global market was valued at US$ 10.5 Bn in 2020
  • It is estimated to expand at a CAGR of 9% from 2021 to 2031
  • The global cell culture industry is expected to reach the value of US$ 27.6 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

In order to increase the availability of immune-boosting medicines, stakeholders in the global market for cell culture should enter into mergers & acquisitions to make optimum use of financial budgets amid the COVID-19 pandemic. Since FBS is linked with potential risk of disease transmission due to prions, bacteria, or viruses, researchers should adopt alternatives to FBS such as human AB serum and thrombin-activated platelet rich plasma to increase the availability of advanced therapy medicinal products. Moreover, favorable reimbursement programs for individuals in Africa and the Middle East are contributing to the expansion of the market for cell culture. Increase in demand for cost-effective and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the production of high-yield cell lines has led to a rise in the number of new product launches.

Leading-edge Cell Culture Products in Demand for Treatment of Chronic Diseases

Advancements in the cell culture market, in terms of innovations in instruments, media, reagents, and sera are benefitting stakeholders in academic institutes, research centers, biotech companies, and pharmaceutical organizations. Launch of advanced cell culture products and demand for novel therapeutics such as biosimilar are expected to boost the growth of the global market throughout the assessment tenure.

Since cell culture is primarily associated with the diagnosis of infections, testing of new drugs, and other R&D activities, the market is projected to expand at a robust CAGR during the forecast period. The high prevalence of chronic diseases such as cancer, diabetes, renal diseases, and cardiovascular diseases is fueling the demand for cell culture activities to increase the availability of treatment options and therapeutic agents.

Request a sample to get extensive insights into the Cell Culture Market

R&D Investments in Immune-boosting Medicines Hold Potentials for Minimizing COVID-19 Risks

The emergence of a new COVID-19 wave in India, China, and the U.K. has brought vaccine companies, biotech companies, and healthcare companies under great scrutiny. In order to win the faith of common individuals and high-risk patients with existing comorbidities, companies in the cell culture market should invest in R&D to innovate and introduce life-saving therapeutics in the market.

Healthcare companies are making use of government stimulus packages and financial schemes provided by the BFSI sector to support research activities in vaccine development and immune-boosting medicines. They should maintain robust supply chains for instruments, sera, media, and reagents to support research activities in academic institutes and biotech companies.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can Alternatives to Fetal Bovine Serum Transform Cell Culture Market?

Fetal bovine serum (FBS) is commonly used as a serum-supplement for the in vitro cell culture of eukaryotic cells. However, ethical issues pertaining to FBS is affecting research activities in the global market for cell culture, since fetal bovine serum is derived from the blood drawn from a bovine fetus via a closed system of collection at the slaughterhouse. Hence, researchers are now resorting to alternatives for FBS such as human AB serum and thrombin-activated platelet-rich plasma to excel in cell culture activities.

Alternatives to FBS are becoming necessary, as, in the past years, advanced therapy medicinal products (ATMP) and cell therapy have become increasingly important in terms of clinical use.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Cell Culture Market

Burgeoning Demand for Biosimilars and Biologic Therapeutics Fueling Market Growth

The high demand for biosimilars and other biologic therapeutics is acting as a key driver for the cell culture industry. This is evident since cell culture helps to increase efficiency & productivity and reduce the cost of manufacture for biologic therapeutics. Healthcare companies are investing in clinical trials to increase the availability of approved biosimilar products. Such advancements are playing an instrumental role in the development of treatment alternatives for chronic diseases in developed as well as developing countries.

Biotech companies are catering to the increase in demand for efficient and cost-effective biosimilars and biologic therapeutics.

Africa and Middle East Offer Lucrative Growth Opportunities to Companies

Apart from Asia Pacific, companies in the cell culture market are witnessing an increase in the per capita income of individuals in countries of Africa and the Middle East. This improvement in the per capita income can be attributed to rising employment and business opportunities for citizens within the country, and also in countries outside of Africa and the Middle East. Thus, investments toward the development of the healthcare infrastructure in Africa and the Middle East are benefitting stakeholders in the market for cell culture.

In many instances, it has been observed that despite having the income for medical treatments, lack of basic healthcare facilities in rural and remote areas of Africa and the Middle East is affecting patient outcomes. In order to improve patient quality of life, companies should set up biotech companies, research institutes, and academic centers in these regions. These developments are necessary due to high prevalence of rare diseases among the people of Africa and the Middle East.

Cell Culture Industry: Overview

  • Cell culture is used in a range of applications such as development of model systems for research, analysis of cellular structures & their mechanisms, drug discovery for treatment of diseases such as Alzheimer’s, stem cell research, drug evaluation, genetic engineering, and production of biologics such as antibodies, vaccines, and proteins
  • Applications such as stem cell research have significant market potential. Stem cell culture assists in standardization of drug production and enables production of various cell lines and related products.
  • Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Hence, further research in the field of stem cell culture for development of drugs presents an opportunity in the market.

Rise in Demand for Cell Culture: Major Driver

  • Manufacturing of biopharmaceuticals involves use of cell culture systems as a unique method of product development as such products are difficult to be produced by conventional pharmaceutical development processes
  • Research & development in the field of biopharmaceuticals that concentrates on discovery of new therapeutics for rare diseases and new mechanisms of drug actions has increased the scope for cell culture in biologics
  • Rise in outsourcing activities and expansion of biopharmaceutical manufacturers are expected to drive the market during the forecast period

Instruments Segment to Dominate Cell Culture Market

  • The global cell culture market has been segmented based on product, end-user, and region
  • In terms of product, the global market has been classified into instruments, media, sera, and reagents. The instruments segment has been split into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. The media segment has been segregated into chemically defined, classical media, protein-free media, Lysogeny media, serum-free media, and specialty media. The sera segment has been bifurcated into fetal bovine serum and others. The reagents segment has been split into albumin, amino acid, attachment factors, growth factors & cytokines, protease inhibitor, thrombin, and others.
  • Increase in trend toward the use of animal-derived component-free media and adoption of chemically defined and specialty media is projected to drive the global market in the near future
  • Moreover, automation of cell culture systems demand more sophisticated instruments and equipment. This is anticipated to boost the growth of the instruments segment.

Asia Pacific to Dominate Cell Culture Business

  • In terms of region, the global cell culture market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Asia Pacific is expected to dominate the global market during the forecast period. This can be attributed to the adoption of new technologies such as next-generation sequencing, higher awareness, increase in healthcare spending in national budgets, early availability of advanced technologies, and higher penetration of research activities across the region.
  • Rise in outsourcing activities and expansion of biopharmaceutical manufacturers are projected to drive the market in Asia Pacific during the forecast period. Moreover, low cost of manufacturing in China and India has led to rise in the production facilities, attracting pharmaceutical & biotechnological companies to the region.

Major Players

  • Key players operating in the global cell culture market include
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Eppendorf AG
    • GE Healthcare
    • Corning Incorporated
    • Becton
    • Dickinson and Company
    • Merck KGaA
    • Lonza
    • VWR International, LLC
    • PromoCell GmbH
  • Each of these players has been profiled in the cell culture market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Cell Culture Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 10.5 Bn

Market Forecast Value in 2031

US$ 27.6 Bn

Growth Rate (CAGR)

9%

Forecast Period

2021–2031

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product
    • Instruments
      • Cell Culture Vessels (Bioreactor)
      • Carbon dioxide Incubators
      • Biosafety Cabinets
      • Cryogenic Tanks
      • Others
    • Media
      • Chemically Defined
      • Classical Media
      • Lysogeny Broth
      • Serum Free
      • Protein Free
      • Specialty Media
    • Sera
      • Fetal Bovine Serum (FBS)
      • Others
    • Reagents
      • Growth Factors & Cytokines
      • Albumin
      • Protease inhibitor
      • Thrombin
      • Attachment Factors
      • Amino Acids
  • End-user
    • Biotechnology & Pharmaceutical & Companies
    • Academics & Research Institutes
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled

  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Eppendorf AG
  • GE Healthcare
  • Corning Incorporated
  • Becton, Dickinson and Company
  • Merck KGaA
  • Lonza
  • VWR International, LLC.
  • PromoCell GmbH

Customization Scope

Available upon request

Pricing

Available upon request

Cell Culture Market – Segmentation

TMR’s study on the global market for cell culture includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global market are discussed in detail.

Product
  • Instruments
    • Cell Culture Vessels (Bioreactor)
    • Carbon Dioxide Incubators
    • Biosafety Cabinets
    • Cryogenic Tanks
    • Others
  • Media
    • Chemically Defined
    • Classical Media
    • Lysogeny Broth
    • Serum Free
    • Protein Free
    • Specialty Media
  • Sera
    • Fetal Bovine Serum (FBS)
    • Others
  • Reagents
    • Growth Factors & Cytokines
    • Albumin
    • Protease inhibitor
    • Thrombin
    • Attachment Factors
    • Amino Acids
End-user
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of cell culture market?

The global market for Cell culture is expected to reach the value of US$ 30 billion by the end of 2028

What is the anticipated CAGR of the market for cell culture in the forecast period?

The global market for cell culture is anticipated to expand at a CAGR of 6.4% from 2021 to 2028

What are the key driving factors for the growth of the cell culture business?

The market is driven by a rise in demand for biopharmaceuticals, an increase in product development by players, and the rapid development of novel vaccines

Which is the rising prominent segment in the global market for cell culture?

The instruments segment dominated the global market in 2020 and the trend is projected to continue during the forecast period

Who are the key players in the global cell culture industry?

Top key players in global market are Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Lonza Group, Sartorius AG, Becton, Dickinson and Company, Corning, Inc., Eppendorf AG, VWR International, PromoCell GmbH, among others

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cell Culture Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cell Culture Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Top 3 players operating in the market space

        5.2. Key Mergers & Acquisitions

        5.3. Technological Advancements

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Cell Culture Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value & Volume Forecast, by Product Type, 2017–2031

            6.3.1. Instruments

                6.3.1.1. Cell Culture Vessels (bioreactor)

                6.3.1.2. Carbon Dioxide Incubators

                6.3.1.3. Biosafety Cabinets

                6.3.1.4. Cryogenic Tanks

                6.3.1.5. Others

            6.3.2. Media Type

                6.3.2.1. Chemically-defined

                6.3.2.2. Classical Media

                6.3.2.3. Lysogeny Broth (LB)

                6.3.2.4. Protein Free

                6.3.2.5. Serum Free

                6.3.2.6. Specialty Media

            6.3.3. Sera

                6.3.3.1. Fetal Bovine

                6.3.3.2. Newborn Calf

                6.3.3.3. Others

            6.3.4. Reagents

                6.3.4.1. Albumin

                6.3.4.2. Amino Acids

                6.3.4.3. Attached Factors

                6.3.4.4. Growth Factors & Cytokines

                6.3.4.5. Protease Inhibitors

                6.3.4.6. Thrombin

                6.3.4.7. Others

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Cell Culture Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value & Volume Forecast, by End-user, 2017–2031

            7.3.1. Biotechnology & Pharmaceutical Companies

            7.3.2. Academic & Research Institutes

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Cell Culture Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value & Volume Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Cell Culture Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value & Volume Forecast, by Product Type, 2017–2031

            9.2.1. Instruments

                9.2.1.1. Cell Culture Vessels (bioreactor)

                9.2.1.2. Carbon Dioxide Incubators

                9.2.1.3. Biosafety Cabinets

                9.2.1.4. Cryogenic Tanks

                9.2.1.5. Others

            9.2.2. Media Type

                9.2.2.1. Chemically-defined

                9.2.2.2. Classical Media

                9.2.2.3. Lysogeny Broth (LB)

                9.2.2.4. Protein Free

                9.2.2.5. Serum Free

                9.2.2.6. Specialty Media

            9.2.3. Sera

                9.2.3.1. Fetal Bovine

                9.2.3.2. Newborn Calf

                9.2.3.3. Others

            9.2.4. Reagents

                9.2.4.1. Albumin

                9.2.4.2. Amino Acids

                9.2.4.3. Attached Factors

                9.2.4.4. Growth Factors & Cytokines

                9.2.4.5. Protease Inhibitors

                9.2.4.6. Thrombin

                9.2.4.7. Others

        9.3. Market Value & Volume Forecast, by End-user, 2017–2031

            9.3.1. Biotechnology & Pharmaceutical Companies

            9.3.2. Academic & Research Institutes

            9.3.3. Others

        9.4. Market Value & Volume Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product Type

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Cell Culture Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value & Volume Forecast, by Product Type, 2017–2031

            10.2.1. Instruments

                10.2.1.1. Cell Culture Vessels (Bioreactor)

                10.2.1.2. Carbon Dioxide Incubators

                10.2.1.3. Biosafety Cabinets

                10.2.1.4. Cryogenic Tanks

                10.2.1.5. Others

            10.2.2. Media Type

                10.2.2.1. Chemically-defined

                10.2.2.2. Classical Media

                10.2.2.3. Lysogeny Broth (LB)

                10.2.2.4. Protein Free

                10.2.2.5. Serum Free

                10.2.2.6. Specialty Media

            10.2.3. Sera

                10.2.3.1. Fetal Bovine

                10.2.3.2. Newborn Calf

                10.2.3.3. Others

            10.2.4. Reagents

                10.2.4.1. Albumin

                10.2.4.2. Amino Acids

                10.2.4.3. Attached Factors

                10.2.4.4. Growth Factors & Cytokines

                10.2.4.5. Protease Inhibitors

                10.2.4.6. Thrombin

                10.2.4.7. Others

        10.3. Market Value & Volume Forecast, by End-user, 2017–2031

            10.3.1. Biotechnology & Pharmaceutical Companies

            10.3.2. Academic & Research Institutes

            10.3.3. Others

        10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product Type

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Cell Culture Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value & Volume Forecast, by Product Type, 2017–2031

            11.2.1. Instruments

                11.2.1.1. Cell Culture Vessels (bioreactor)

                11.2.1.2. Carbon Dioxide Incubators

                11.2.1.3. Biosafety Cabinets

                11.2.1.4. Cryogenic Tanks

                11.2.1.5. Others

            11.2.2. Media Type

                11.2.2.1. Chemically-defined

                11.2.2.2. Classical Media

                11.2.2.3. Lysogeny Broth (LB)

                11.2.2.4. Protein Free

                11.2.2.5. Serum Free

                11.2.2.6. Specialty Media

            11.2.3. Sera

                11.2.3.1. Fetal Bovine

                11.2.3.2. Newborn Calf

                11.2.3.3. Others

                11.2.3.4. Total

            11.2.4. Reagents

                11.2.4.1. Albumin

                11.2.4.2. Amino Acids

                11.2.4.3. Attached Factors

                11.2.4.4. Growth Factors & Cytokines

                11.2.4.5. Protease Inhibitors

                11.2.4.6. Thrombin

                11.2.4.7. Others

        11.3. Market Value & Volume Forecast, by End-user, 2017–2031

            11.3.1. Biotechnology & Pharmaceutical Companies

            11.3.2. Academic & Research Institutes

            11.3.3. Others

        11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product Type

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Cell Culture Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value & Volume Forecast, by Product Type, 2017–2031

            12.2.1. Instruments

                12.2.1.1. Cell Culture Vessels (bioreactor)

                12.2.1.2. Carbon Dioxide Incubators

                12.2.1.3. Biosafety Cabinets

                12.2.1.4. Cryogenic Tanks

                12.2.1.5. Others

            12.2.2. Media Type

                12.2.2.1. Chemically-defined

                12.2.2.2. Classical Media

                12.2.2.3. Lysogeny Broth (LB)

                12.2.2.4. Protein Free

                12.2.2.5. Serum Free

                12.2.2.6. Specialty Media

            12.2.3. Sera

                12.2.3.1. Fetal Bovine

                12.2.3.2. Newborn Calf

                12.2.3.3. Others

            12.2.4. Reagents

                12.2.4.1. Albumin

                12.2.4.2. Amino Acids

                12.2.4.3. Attached Factors

                12.2.4.4. Growth Factors & Cytokines

                12.2.4.5. Protease Inhibitors

                12.2.4.6. Thrombin

                12.2.4.7. Others

        12.3. Market Value & Volume Forecast, by End-user, 2017–2031

            12.3.1. Biotechnology & Pharmaceutical Companies

            12.3.2. Academic & Research Institutes

            12.3.3. Others

        12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product Type

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Cell Culture Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value & Volume Forecast, by Product Type, 2017–2031

            13.2.1. Instruments

                13.2.1.1. Cell Culture Vessels (bioreactor)

                13.2.1.2. Carbon Dioxide Incubators

                13.2.1.3. Biosafety Cabinets

                13.2.1.4. Cryogenic Tanks

                13.2.1.5. Others

            13.2.2. Media Type

                13.2.2.1. Chemically-defined

                13.2.2.2. Classical Media

                13.2.2.3. Lysogeny Broth (LB)

                13.2.2.4. Protein Free

                13.2.2.5. Serum Free

                13.2.2.6. Specialty Media

            13.2.3. Sera

                13.2.3.1. Fetal Bovine

                13.2.3.2. Newborn Calf

                13.2.3.3. Others

            13.2.4. Reagents

                13.2.4.1. Albumin

                13.2.4.2. Amino Acids

                13.2.4.3. Attached Factors

                13.2.4.4. Growth Factors & Cytokines

                13.2.4.5. Protease Inhibitors

                13.2.4.6. Thrombin

                13.2.4.7. Others

        13.3. Market Value & Volume Forecast, by End-user, 2017–2031

            13.3.1. Biotechnology & Pharmaceutical Companies

            13.3.2. Academic & Research Institutes

            13.3.3. Others

        13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product Type

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix

        14.2. Market Share Analysis, by Company, 2020

        14.3. Company Profiles

            14.3.1. Thermo Fisher Scientific, Inc.

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Strategic Overview

            14.3.2. Merck KGaA

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Strategic Overview

            14.3.3. Cytiva (Danaher Corporation)

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Strategic Overview

            14.3.4. Becton, Dickinson and Company

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Strategic Overview

            14.3.5. Corning Incorporated

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Strategic Overview

            14.3.6. Eppendorf SE

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Strategic Overview

            14.3.7. HiMedia Laboratories

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Strategic Overview

            14.3.8. Sartorius AG

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Strategic Overview

            14.3.9. FUJIFILM Irvine Scientific, Inc.

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Strategic Overview

            14.3.10. InvivoGen

                14.3.10.1. Company Overview

                14.3.10.2. Product Portfolio

                14.3.10.3. SWOT Analysis

                14.3.10.4. Strategic Overview

            14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)

                14.3.11.1. Company Overview

                14.3.11.2. Product Portfolio

                14.3.11.3. SWOT Analysis

                14.3.11.4. Strategic Overview

            14.3.12. Miltenyi Biotec

                14.3.12.1. Company Overview

                14.3.12.2. Product Portfolio

                14.3.12.3. SWOT Analysis

                14.3.12.4. Strategic Overview

            14.3.13. STEMCELL Technologies, Inc.

                14.3.13.1. Company Overview

                14.3.13.2. Product Portfolio

                14.3.13.3. SWOT Analysis

                14.3.13.4. Strategic Overview

            14.3.14. Solida Biotech GmbH

                14.3.14.1. Company Overview

                14.3.14.2. Product Portfolio

                14.3.14.3. SWOT Analysis

                14.3.14.4. Strategic Overview

            14.3.15. Caisson Labs, Inc.

                14.3.15.1. Company Overview

                14.3.15.2. Product Portfolio

                14.3.15.3. SWOT Analysis

                14.3.15.4. Strategic Overview

            14.3.16. Cellexus

                14.3.16.1. Company Overview

                14.3.16.2. Product Portfolio

                14.3.16.3. SWOT Analysis

                14.3.16.4. Strategic Overview

            14.3.17. Pierre Guerin

                14.3.17.1. Company Overview

                14.3.17.2. Product Portfolio

                14.3.17.3. SWOT Analysis

                14.3.17.4. Strategic Overview

    List of Table

    Table 01: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 03: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 04: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 05: Global Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 06: Global Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 07: Global Cell Culture Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 08: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 09: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 10: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 11: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 12: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 13: North America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 14: North America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 15: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 17: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 18: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 19: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 20: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 21: Europe Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 22: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, by Country/Sub-region, 2017–2031

    Table 23: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 24: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 25: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 26: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 27: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 28: Asia Pacific Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 29: Latin America Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 30: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 31: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 32: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 33: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 34: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 35: Latin America Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 36: Middle East & Africa Cell Culture Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 37: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Product, 2017–2031

    Table 38: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 39: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Media, 2017–2031

    Table 40: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031

    Table 41: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 42: Middle East & Africa Cell Culture Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Cell Culture Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Cell Culture Market Value Share, by Product, 2020

    Figure 03: Global Cell Culture Market Value Share, End-user, 2020

    Figure 04: Global Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

    Figure 05: Global Cell Culture Market Revenue (US$ Mn), by Instruments, 2017–2031

    Figure 06: Global Cell Culture Market Revenue (US$ Mn), by Media, 2017–2031

    Figure 07: Global Cell Culture Market Revenue (US$ Mn), by Sera, 2017–2031

    Figure 08: Global Cell Culture Market Revenue (US$ Mn), by Reagents, 2017–2031

    Figure 09: Global Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

    Figure 10: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 11: Global Cell Culture Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017–2031

    Figure 12: Global Cell Culture Market Revenue (US$ Mn), by Academic and Research Institutes, 2017–2031

    Figure 13: Global Cell Culture Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 14: Global Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 15: Global Cell Culture Market Attractiveness Analysis, by Region, 2021–2031

    Figure 16: Global Cell Culture Market Value Share Analysis, by Region, 2020 and 2031 

    Figure 17: North America Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 18: North America Cell Culture Market Analysis Value Share Analysis, by Country, 2020 and 2031

    Figure 19: North America Cell Culture Market Analysis Attractiveness Analysis, by Country 2021–2031

    Figure 20: North America Cell Culture Market Attractiveness Analysis, by Product, 2021–2031

    Figure 21: North America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

    Figure 22: North America Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 23: North America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 24: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 25: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 26: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 27: Europe Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

    Figure 28: Europe Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

    Figure 29: Europe Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 30: Europe Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 31: Asia Pacific Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

    Figure 32: Asia Pacific Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 33: Asia Pacific Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 34: Asia Pacific Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

    Figure 35: Asia Pacific Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

    Figure 36: Asia Pacific Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 37: Asia Pacific Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 38: Latin America Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

    Figure 39: Latin America Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 40: Latin America Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 41: Latin America Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

    Figure 42: Latin America Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

    Figure 43: Latin America Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 44: Latin America Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 45: Middle East & Africa Cell Culture Market Value (US$ Mn) Analysis & Forecast, 2017–2031

    Figure 46: Middle East & Africa Cell Culture Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 47: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 48: Middle East & Africa Cell Culture Market Attractiveness Analysis, by Technique, 2021–2031

    Figure 49: Middle East & Africa Cell Culture Market Value Share Analysis, by Product, 2020 and 2031

    Figure 50: Middle East & Africa Cell Culture Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 51: Middle East & Africa Cell Culture Market Value Share Analysis, by End-user, 2020 and 2031

Copyright © Transparency Market Research, Inc. All Rights reserved